deltatrials
Completed PHASE2 NCT00028353

A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)

Sponsor: GTx

Conditions Prostatic Intraepithelial Neoplasia
Interventions GTX-006 (Acapodene)
Updated 6 times since 2017 Last updated: Nov 13, 2013 Started: Apr 30, 2001 Completion: Jul 31, 2003

This PHASE2 trial investigates Prostatic Intraepithelial Neoplasia and is currently completed. GTx leads this study, which shows 6 recorded versions since 2001 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GTx
Data source: GTx

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States, Aventura, United States, Bala-Cynwyd, United States, Bay Shore, United States, Cincinnati, United States, Couer D'Alene, United States, Huntsville, United States, Indianapolis, United States, Lancaster, United States, Las Vegas, United States and 14 more location s